Kim Tsuchimoto
Net worth: 747 049 $ as of 2026-05-30
Net worth: 747 049 $ as of 2026-05-30
Ms. Kim R.
Tsuchimoto, CPA, is an Independent Director at Thiogenesis Therapeutics Corp.
She is on the Board of Directors at Thiogenesis Therapeutics Corp., Monopar Therapeutics, Inc. and Thiogenesis Therapeutics, Inc. /New/.
Ms. Tsuchimoto was previously employed as a Chief Financial Officer by Mercaptor Discoveries, Inc., a Treasurer, VP-International Finance & Tax by Horizon Pharmaceutical LLC, a VP-Financial Planning & Analysis, Internal Control by Raptor Pharmaceuticals Corp., a Chief Financial Officer, Secretary & Treasurer by Raptor Pharmaceutical, Inc., a Controller by International Microcomputer Software, Inc., a Controller & Assistant Vice President by SpatiaLight, Inc., a Vice President-Treasurer & Controller by BioMarin Pharmaceutical, Inc., and a Treasurer, Vice President & Controller by Glyko, Inc. She received her undergraduate degree from San Francisco State University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-30 | 11,486 ( 0.17% ) | 747 049 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| MONOPAR THERAPEUTICS INC. | Director/Board Member | 2023-02-28 |
| THIOGENESIS THERAPEUTICS, CORP. | Director/Board Member | 2022-03-30 |
| Companies | Position | End |
|---|---|---|
Mercaptor Discoveries, Inc.
Mercaptor Discoveries, Inc. Pharmaceuticals: MajorHealth Technology Engages in manufacturing drugs | Founder | 2019-07-31 |
Raptor Pharmaceuticals Corp.
Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops drugs and drug-delivery platforms | Director of Finance/CFO | 2015-04-30 |
International Microcomputer Software, Inc.
International Microcomputer Software, Inc. Packaged SoftwareTechnology Services Develops software for productivity, utility, and digital image categories | Comptroller/Controller/Auditor | 2006-02-28 |
| SPATIALIGHT, INC. | Comptroller/Controller/Auditor | 2005-08-22 |
| BIOMARIN PHARMACEUTICAL INC. | Comptroller/Controller/Auditor | 2005-05-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 11 |
|---|---|
International Microcomputer Software, Inc.
International Microcomputer Software, Inc. Packaged SoftwareTechnology Services Develops software for productivity, utility, and digital image categories | Technology Services |
SpatiaLight, Inc.
SpatiaLight, Inc. Electronics/AppliancesConsumer Durables Supplies photographic equipment | Consumer Durables |
BioMarin Pharmaceutical, Inc.
BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Raptor Pharmaceutical, Inc.
Raptor Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and drug-delivery platforms | Health Technology |
Glyko, Inc.
Glyko, Inc. Medical SpecialtiesHealth Technology Discovers, develops, and commercializes carbohydrate enzyme therapeutics | Health Technology |
San Francisco State University
San Francisco State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Raptor Pharmaceuticals Corp.
Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops drugs and drug-delivery platforms | Health Technology |
Horizon Pharmaceutical LLC
Horizon Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of life-altering therapeutics that treat debilitating and often fatal diseases | Health Technology |
Monopar Therapeutics, Inc.
Monopar Therapeutics, Inc. BiotechnologyHealth Technology Develops drugs for cancer disease | Health Technology |
Mercaptor Discoveries, Inc.
Mercaptor Discoveries, Inc. Pharmaceuticals: MajorHealth Technology Engages in manufacturing drugs | Health Technology |
Thiogenesis Therapeutics Corp.
Thiogenesis Therapeutics Corp. Financial ConglomeratesFinance Processes drugs in pharmaceutical preparations | Finance |
Select your edition
All financial news and data tailored to specific country editions